Biologic and Biosimilar Therapies: APP Management Protocols
Biologic and biosimilar therapies management protocols for APPs covering initiation, monitoring, safety considerations and treatment optimiz
The safety and effectiveness of care hinges on the biologic and biosimilar therapies: APP management protocols, which help provide outcome driven care to patients with inflammatory bowel disease (IBD).
While the biologic and biosimilar APP management protocols provide a clinical framework for the appropriate initiation, monitoring, adjustments, and long-term control of disease management for IBD, it is the advance practice providers that are the key to its success.
With the valuable resources, expert guidance and professional connections that the IBD Community Network provides, APPs are well-positioned to drive positive changes.
